Dr. Matthew Boente MD received his degree in medicine from Rush Medical College. He completed his residency in Obstetrics and Gynecology at Rush Presbyterian Medical Center. Prior to his fellowship at Duke University’s Division of Gynecologic Oncology, Dr. Boente trained under the Galloway Fellowship at the Department of Surgery, Gynecology Division at Memorial-Sloan Kettering Cancer Center in New York.

Dr. Matthew Boente MD received his certification with a subspecialty in Gynecologic Oncology from the American Board of Obstetrics and Gynecology. From 2017 to 2018, Dr. Boente worked as Medical Director, U.S. Medical Affairs, Gyn-Oncology at Genentech Inc. in San Francisco, where he led a large global cross-functional team responsible for the FDA approval of bevacizumab with chemotherapy in front line ovarian cancer.

Dr. Matthew Boente MD  has received awards for his medical practice, including the  Surgical Sciences Award, First Place and ORTHO Pharmaceutical Resident Teaching Award, First Place from Rush Presbyterian St. Luke’s Medical Center; Presidential Research Award, First Place from Chicago Gynecology Society, and Gold Certificate of Excellence Award from the National Cancer Institute.

With many years of experience in the medical field, Dr. Matthew Boente MD holds memberships and offices in professional societies, including the American Medical Association, American Association for Cancer Research, American Society of Clinical Oncology, Gynecology Oncology Group, International Gynecologic Oncology Society, Mid-Atlantic Gynecologic Oncology Society, and Society of Surgical Oncologists.